[Organization of Gaucher disease management in France]

Rev Med Interne. 2007 Oct:28 Suppl 2:S198-201. doi: 10.1016/s0248-8663(07)78882-3.
[Article in French]

Abstract

Gaucher disease management in France is facilitated by CETG (Comitee of Evaluation and Treatment of Gaucher disease). Four hundred and fifty-six patients are enrolled in 2006 in the French Gaucher registry of CETG. Two hundred and thirty patients had treatment. Eighty five % are type 1, 10.5% type 2 and 5.5% type 3. Only 1 patient had a saposin C deficiency. Information on CETG is available on www.cetl.net.

Publication types

  • Comparative Study

MeSH terms

  • 1-Deoxynojirimycin / analogs & derivatives
  • 1-Deoxynojirimycin / therapeutic use
  • Adolescent
  • Adult
  • Aged
  • Child
  • Child, Preschool
  • Enzyme Inhibitors / therapeutic use
  • Female
  • France / epidemiology
  • Gaucher Disease / complications
  • Gaucher Disease / drug therapy
  • Gaucher Disease / epidemiology
  • Gaucher Disease / genetics
  • Gaucher Disease / therapy*
  • Glucosylceramidase / therapeutic use
  • Hospitalization
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Parkinsonian Disorders / complications
  • Registries*
  • Saposins / deficiency
  • Treatment Outcome

Substances

  • Enzyme Inhibitors
  • Saposins
  • 1-Deoxynojirimycin
  • miglustat
  • Glucosylceramidase
  • imiglucerase